Biodesix, Inc. (BDSX:NASDAQ) closed at $23.99 on October 14, 2026, down 4.04% on the day. The stock trades 25.0% below its 52-week high of $31.97 and 356.1% above its 52-week low of $5.26. Over the past year, it gained 223.3%. Biodesix, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -6.65% | -13.39% | +18.82% | +82.16% | +223.32% |
In 252 trading sessions since October 14, 2025, BDSX closed higher on 122 days (48%). Its best day was January 12, 2026 (+47.99%) and its worst was January 26, 2026 (-14.05%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 2 times.
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Find more stocks like BDSX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.